Radient Technologies (Radient Technologies) Debt-to-Equity : -0.90 (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies Debt-to-Equity?

Radient Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $9.49 Mil. Radient Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.51 Mil. Radient Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $-11.05 Mil. Radient Technologies's debt to equity for the quarter that ended in Dec. 2022 was -0.90.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Radient Technologies's Debt-to-Equity or its related term are showing as below:

RDDTF's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Radient Technologies Debt-to-Equity Historical Data

The historical data trend for Radient Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies Debt-to-Equity Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Debt-to-Equity

Get a 7-Day Free Trial

0.09

0.13

0.79

-4.70

-1.35

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-Equity	Get a 7-Day Free Trial															-1.71	-1.35	-1.17	-1.00	-0.90

Competitive Comparison of Radient Technologies's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radient Technologies's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Radient Technologies's Debt-to-Equity falls into.

Radient Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Radient Technologies's Debt to Equity Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10.657	+	0.127)	/	-7.998
	=	-1.35

Radient Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.488	+	0.506)	/	-11.053
	=	-0.90

Radient Technologies (OTCPK:RDDTF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Radient Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Radient Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.